Study to Investigate the Efficacy and Safety of an Investigational Medication in Patients with Alopecia Areata

Last Updated:
United States
Age 12+; diagnosed with alopecia areata (50% or greater scalp hair loss)
Pfizer, Inc.

A clinical research study is currently looking for adolescents and adults with alopecia areata who have lost 50% or more of the hair on their head to participate in a study of an investigational medication.

During the course of this study, some people will receive the investigational medication and some will receive an inactive medication called a placebo. The study will explore whether the study drug is safe and can help AA patients regrow hair. The study drug, using different doses, will be compared to an inactive placebo (dummy drug).

You may qualify to participate if you:

  • are 12 years of age or older
  • have been diagnosed with alopecia areata
  • have at least 50% scalp hair loss*
*study doctor will assess your amount of hair loss.

If you or someone you know is interested in joining this clinical trial, please visit where you’ll find more information about the study and to obtain contact information for a study center near you.

Alternatively, You Can Contact The Following Trial Sites For More Information About Participation In The Study:

University of Alabama at Birmingham
Birmingham, AL
Contact: Rhonda K. Kaler
Phone: 205-502-9967

University of California, Irvine
Dermatology Clinical Research Center
Irvine, CA
Investigator: Natasha A. Mesinkovska, MD, PhD
Phone: 949-824-7103

Dermatology Specialists, Inc.
Murrieta, CA
Contact: Alice Davis
Phone: 951-304-7546 Ext 3633

Southern California Dermatology, Inc.
Santa Ana, CA
Contact: Michelle Laubach
Phone: 714-547-5151

Kaiser Permanente Clinical Trials Unit
San Francisco, CA
Contact: Daisy Mendoza-Zepeda
Phone: 415-833-3480

University of California, San Francisco
San Francisco, CA
Contact: Christine Aroyan
Phone: 415-353-9684

Mosaic Dermatology
Santa Monica, CA
Investigator: Vandana Madkan, MD

University of Colorado Anschutz Medical Campus
Aurora, CO
Investigator: Cory Dunnick, MD
Phone: 720-848-0500

Yale School of Medicine
New Haven, CT
Contact: Rebecca M. Chawarski
Phone: 203-737-8830

Medstar Georgetown University Hospital
Washington, DC
Contact: Patricia Tanjutco

Siperstein Dermatology Group
Boynton Beach, FL
Contact: Marta Narvaez
Phone: 561-364-7774 Ext 323

Park Avenue Dermatology
Orange Park, FL
Contact: Victoria Tester
Phone: 904-458-0411

Forward Clinical Trials, Inc.
Tampa, FL
Contact: Michelle Laubach
Phone: 813-264-2155

Advanced Clinical Research
Treasure Valley Dermatology & Skin Cancer Center
Boise, ID
Investigator: Ryan Harris, MD
Phone: 208-377-8653 Ext 201

Northwestern Medical Group
Chicago, IL
Contact: Swarnalatha Nagiredla
Phone: 312-503-5902

NorthShore University HealthSystem Dermatology
Clinical Trials Unit
Skokie, IL
Contact: Cristina Fernandez
Phone: 847-663-8530

Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN
Phone: 317-516-5030

Massachusetts General Hospital
Boston, MA
Phone: 617-726-5066

University of Minnesota
Minneapolis, MN
Contact: Irmina Wallander
Phone: 612-624-5721

UNC Dermatology Clinical Trials Unit
Chapel Hill, NC
Investigator: Aida Lugo-Somolinos, MD
Phone: 984-974-3672

Icahn School of Medicine at Mount Sinai
New York, NY
Contact: Rachel Karalekas 
Phone: 212-241-3288

NYU School of Medicine
New York, NY
Contact: Susan Cataldo
Phone: 212-263-5244

Skin Specialists, PC
Omaha, NE
Contact: Ashley Bell
Phone: 402-697-6599

The Dermatology Group, PC
Verona, NJ
Contact: Mia Johnson
Phone: 973-571-2121 Ext 5891

The Cleveland Clinic
Cleveland, OH
Contact: Lisa Rittwage | Phone: 216-444-4659
Contact: Beverly Doyle | Phone: 216-636-1196

Vital Prospects Clinical Research Institute, PC
Tulsa, OK
Phone: 918-392-4550